INVITED LECTURER | TITLE OF THE SPEECH | COUNTRY |
Erik DE CLERCQ | Opening Lecture
The antiviral drug era: half a century after the synthesis of the first antiviral drug | Belgium |
Esin AKI | Computer Aided Drug Design Studies on Chemotherapeutically Active Heterocyclic Compounds | Turkey |
Tunç AKKOÇ | Allergen spesific immunotheraphy in allergic disease | Turkey |
Feyza ARICIOĞLU | Glutamatergic system and its role in neurobiology of psychiatric disorders | Turkey |
Tuncer ARSLAN | The Effects of Patent Protection in Turkish Pharmaceutical Industry | Turkey |
Esen BELLUR | Research and Development in drug synthesis | Turkey |
Bezhan CHANKVETADZE | New materials and technologies for separation of chiral drugs | Germany |
Rasmus P. CLAUSEN | Design and synthesis of selective glutamate receptor agonists | Denmark |
Elisabeth COLBOURN | Mathematical modelling of pharmaceutical processes using neural and evolutionary computing techniques | UK |
Paolo COLOMBO | Dry powder inhalers: construction of antibiotic microparticles for lung infection treatment | Turkey |
Yılmaz ÇAPAN | Brain Drug Targeting | Turkey |
Salvatore GUCCIONE | Translating information about biochemical pathways into practical, small organic or peptidomimetic therapeutic agents | Italy |
Rolf W. HARTMANN | From target identifcation, hit discovery to lead optimisation: recent examples from our research | Germany |
Michael HEINRICH | Title will be announced | UK |
Candan HIZEL | Pharmacogenetics/genomics forPredictiveandPersonalizedMedicine in Post GenomicEra | France |
Jeff IDLE | The metabolomics revolution in drug metabolism | USA |
Fikret Vehbi İZZETTİN | Development of Clinical Pharmacy and Pharmaceutical Care in Turkey | Turkey |
Joachim JOSE | New potent inhibitors of human protein kinase CK2, a target in neoplastic diseases | Germany |
Emin KANSU | Current perspectives on molecular targeting in cancer therapy | Turkey |
Neerja KAUSHIK–BASU | Inhibitors of Hepatitis C Virus Replication | USA |
Ertuğrul KILIÇ | The roles of Multidrug resistance transporter (Mdr)-1 and Multidrug resistance-associated protein (Mrp)-1 in the treatment of stroke | Turkey |
Gülden Z. OMURTAG | Toxicity of Mycotoxins | Turkey |
Hayat ÖNYÜKSEL | Peptide Drug Delivery Using Phospholipid Nanomicelles | USA |
Nicholas PEPPAS | Advances Responsive and Feedback-Controlled Nanoparticles for Drug and Protein Delivery | USA |
Erhan PİŞKİN | Antisense Technologies | Turkey |
Domenico PRATICO | Novel enzymatic pathways in Alzheimer's disease pathogenesis | USA |
Russel REITER | Melatonin: Mechanisms as an Antioxidant and Clinical Applications | USA |
Rana SANYAL | Functional Macromolecules for Drug Delivery | Turkey |
Sena SEZEN | Diabetic neuropathy: New insights into the pathophysiology and treatment. | USA |
Dharmarajan SRIRAM | Recentdevelopments in anti-TB drugdiscovery | India |
Howard STEVENS | The role of gamma scintigraphy in pharmaceutical product development | Scotland |
Semra ŞARDAŞ | Pharmacogenetics is the important component of pharmacovigilance | Turkey |
Jacques TURGEON | Title will be announced | Canada |
Murat TÜRKOĞLU | Development of dermal and oral products based on tea extracts | Turkey |
Fikriye URAS | Potential protein drugs: New protein K dependent proteins and their receptors | Turkey |
Mert ÜLGEN | In vitro drug metabolism studies : What have we learned from biotransformation of amines ? | Turkey |
Hermann WATZIG | Understanding protein properties: essential for proteomics, quality control, binding assays and molecular modelling | Germany |
Yasemin YAZAN | What are the novelties in cosmetic science: expectations and responses | Turkey |
Berrak YEĞEN | Gender Difference in Science | Turkey |
Kemal YELEKÇİ | De Novo Design of Selective Monoamine Oxidase A and B Inhibitors :
Evaluation of Novel Pyrazoline derivatives using Molecular Modeling Techniques | Turkey |
Gülgün YENER | Usage of nanotechnology and biotechnology in cosmetology | Turkey |
Erdem YEŞİLADA | Scientific Evaluation of Turkish folk remedies for wound healing | Turkey |
